Big Pharma may cut South African investment in generics row

18-01-2014 BusinessDayComments (0)


Global drug firms may cut their South African investments as part of a campaign against Pretoria's plans to overhaul its intellectual property laws to favour generic production, media documents show. South Africa is in the final stages of implementing ...

Read more on BusinessDay

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top